CD226 : a potent driver of antitumor immunity that needs to be maintained
| Errataetall: |
CommentOn: Immunity. 2020 Oct 13;53(4):805-823.e15. - PMID 33053330 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Cellular & molecular immunology - 19(2022), 9 vom: 08. Sept., Seite 969-970 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bi, Jiacheng [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comment |
|---|
| Anmerkungen: |
Date Completed 31.08.2022 Date Revised 02.09.2023 published: Print-Electronic CommentOn: Immunity. 2020 Oct 13;53(4):805-823.e15. - PMID 33053330 Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41423-020-00633-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM319839117 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM319839117 | ||
| 003 | DE-627 | ||
| 005 | 20231225172315.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41423-020-00633-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1066.xml |
| 035 | |a (DE-627)NLM319839117 | ||
| 035 | |a (NLM)33420352 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bi, Jiacheng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a CD226 |b a potent driver of antitumor immunity that needs to be maintained |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.08.2022 | ||
| 500 | |a Date Revised 02.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Immunity. 2020 Oct 13;53(4):805-823.e15. - PMID 33053330 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Receptors, Virus |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Cellular & molecular immunology |d 2004 |g 19(2022), 9 vom: 08. Sept., Seite 969-970 |w (DE-627)NLM158038010 |x 2042-0226 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2022 |g number:9 |g day:08 |g month:09 |g pages:969-970 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41423-020-00633-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2022 |e 9 |b 08 |c 09 |h 969-970 | ||